If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Share News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Horizon Discovery Leaders Buy 100,000

Mon, 04th May 2020 14:36

(Alliance News) - The follow is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Horizon Discovery Group PLC - Board members buy more than 100,000 shares at 102.0 pence to 102.92p, worth just over GBP100,000 on Friday last week and Monday. Chief Financial Officer Jayesh Pankhania buys 44,123 and Chief Executive Officer Terry Pizzie and Non-Executive Chair Ian Gilham each buy 20,000 on Friday, while Non-Executive Director Susan Searle buys 20,000 on Monday. Pankhania now has 90,768 shares for a 0.06% stake, while Pizzie has 42,285, Gilham has 90,037, and Searle has 74,691.

----------

Polar Capital Holdings PLC - Non-Executive Director Andrew Ross buys 25,000 shares at 418.78p, worth GBP104,695, on Friday last week.

----------

Enquest PLC - Non-Executive Director Howard Paver buys 433,276 shares at GBP0.116, worth GBP50,260, on Thursday last week.

----------

Blackbird PLC - Chief Operating Officer & CFO Stephen White buys 65,000 shares at 15.5p, worth GBP10,075, on Monday. Now holds 279,286 shares, a 0.08% stake.

----------

Gresham House Energy Storage Fund PLC - Non-Executive Director Cathy Pitt buys 9,660 shares at 103p, worth GBP9,950, on Monday. Now 14,660 shares.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 May 2018 16:15

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 2 May Direct Line Insurance GroupQ1 ResultsConvaTec GroupQ1 GroupHalf

Read more
14 Feb 2017 09:15

Horizon Discovery looks to grow revenue as it teams up with pharmaceutical

(ShareCast News) - Gene editing technology company Horizon Discovery has teamed up with a global pharmaceutical to support its drug discovery developments as it aims to increase revenue in 2017. The AIM-listed company penned a master service agreement with the pharmaceuticals adding to its original

Read more
24 Jan 2017 10:44

Horizon Discovery's full year revenue rises as volumes increase

(ShareCast News) - Horizon Discovery Group, a maker of gene editing technologies, saw revenue increased last year, driven by better-than-expected sales volumes. For the 2016 calendar year, revenue climbed 19% to £24m compared to the previous year, with gross margin increasing to the mid-50% range, f

Read more
24 Jan 2017 09:47

Horizon Discovery Targets Positive Earnings In Current Year

Read more
16 Nov 2016 10:01

Horizon Disc gains Chinese partnerships to develop tumor diagnostic kit

(ShareCast News) - Horizon Discovery, a developer of gene editing technologies, has entered into partnerships with three Chinese diagnostic kit developers to treat tumours. The company will provide HDx Reference Standards for next generation sequencing assay development, clinical trials, and for inc

Read more
19 Oct 2016 13:59

Horizon Discovery inks subscription-based licensing deal

(ShareCast News) - Horizon Discovery has inked a subscription-based licensing deal for its biomanufacturing cell lines. The deal, the first of its type for the company and with an unnamed commercial partner, is worth a minimum of £500,000. "We look forward to making further announcements in this are

Read more
19 Oct 2016 07:23

Horizon Discovery Signs Licensing Deal With GBP500,000 Minimum Value

Read more
6 Sep 2016 09:53

Horizon Discovery Inks CRISPR Platform Deal With Fulcrum Therapeutics

Read more
1 Sep 2016 11:13

Horizon Discovery signs development agreement with Ventanta

(ShareCast News) - Gene editing technologies company Horizon Discovery Group announced on Thursday that it has entered into a co-development and commercialisation agreement with Ventana Medical Systems, a member of the Roche Group. The AIM-traded firm said the agreement covers the development, manuf

Read more
17 Jun 2016 15:06

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Jun 2016 07:52

Horizon Discovery Says Qiagen Incorporates Reference Standards

Read more
12 May 2016 08:04

Horizon Discovery Signs Deals With Next Generation Sequencing Firm

Read more
11 May 2016 08:37

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

Read more
11 May 2016 07:22

LONDON BRIEFING: Compass Group Up But TUI Down Following Updates

Read more
26 Apr 2016 15:43

Revenues grow, losses widen at Horizon Discovery

(ShareCast News) - Gene-editing technology company Horizon Discovery Group saw revenues grow sizably in the 2015 calendar year, it reported on Tuesday, though losses also widened. The AIM-traded firm reported a 69% increase in total group revenue to £20.2m, with product revenues growing 124% to £7.8

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.